Contact

Thabor Therapeutics Team

Management Team

Jérémie Mariau
CEO

Jérémie Mariau

CEO

Read bio
Stéphanie Beq
R&D Director

Stéphanie Beq

R&D Director

Read bio

Scientific & Clinical Founders

Inserm
Head of U1242 unit (Rennes, France)

Doctor

Eric Chevet

Read bio
Inserm
U1242 unit
(Rennes, France)

Doctor

Eric Ogier-Denis

Read bio
Gastroenterologist
Co-founder of Institut des MICI (Paris, France)

Professor

Xavier Treton

Read bio

Scientific Advisory Board

Thabor Tx has built a world-class scientific advisory Board composed of AGR2 and IBD experts:

  • Xavier Treton, MD, PhD, gastro-enterology, former APHP, Institut des MICI (Paris, France)
  • Eric Chevet, PhD, biochemistry, Inserm (Rennes, France)
  • Eric Ogier, PhD, translational sciences, Inserm (Rennes, France)
  • Marla Dubinsky, MD, PhD, gastro-enterology, Mount Sinai School of Medicine (NY, USA)
  • Silvio Danese, MD, PhD, gastro-enterology, San Raffaele Hospital (Milano, Italy)
  • Mathurin Fumery, MD, PhD, gastro-enterology, CHU Amiens (Amiens, France)
  • Laurent Peyrin-Biroulet, MD, PhD, gastro-enterology, CHU Nancy (Nancy, France)
  • Frederic Delom, PhD, cell biology, Inserm (Bordeaux, France)

Where to find us

BioLabs Hôtel-Dieu
1 Parvis Notre-Dame, Place Jean-Paul II
75004 Paris
France

Headquarters

4 rue Thénard
75005 Paris
France

Linkedin

Copyright 2023 Thabor Therapeutics – Legal mentions

Jérémie Mariau

Jérémie Mariau is a healthcare entrepreneur with more than 15 years of experience at running cutting-edge biologics programs in various biotech companies.

Before joining Thabor Tx, Jérémie was CEO of ILTOO Pharma, a clinical stage biotech company focused on autoimmune/inflammatory diseases. Prior to that, Jérémie was COO of Alfact Innovation, a company co-founded by Pr C. Bréchot, and consultant at Alcimed.

Jérémie holds a MSc in Human Genetics from University Paris Diderot and a life science engineer degree from Montpellier SupAgro. He also holds a Master in Management of Innovation in life sciences industry from AgroParisTech and Reims Management School.

Stéphanie Beq

Stéphanie spent more than 15 years in immunology / R&D at developing biologics. Before joining Thabor Tx, Stéphanie was R&D Director at Alexion France, and Senior Director at HifiBio, Stallergenes, and Cytheris.


Stéphanie holds a PhD in Medical Virology and got a 4-year post-doctoral position at Pasteur Institute in Nobel Prize laureate Dr. F. Barre-Sinoussi’s laboratory.

Eric Chevet

Thabor co-founder, Eric Chevet is a biochemist. He is head of INSERM Unit 1242 employing more than 100 researchers dedicated to stress signals in oncology and gastroenterology.

He published more than 200 publications and filed 9 patent applications. He also co-founded Cell Stress Discoveries Ltd.

Eric Ogier-Denis

Thabor co-founder, Eric Ogier-Denis is a translational biologist. He is research director of INSERM Unit 1242. He is an expert in IBD pathophysiology and associated animal models.

He filed 14 patent applications and co-founded Inception IBD, a company financed by Versant Partners.

Xavier Treton

Xavier Treton is a gastroenterologist and co-founder of Institut des MICI. He was the former head of gastrointestinal service and tissue bank at Beaujon Paris hospital, well-known for clinical trials in IBD (APHP, largest European cluster of hospitals).

He co-founded Inception IBD, a company financed by Versant Partners.

He is member of the board of the GETAID, a national association to promote IBD studies in France and Europe with 47 affiliated medical centers.